- Trials with a EudraCT protocol (38)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (1)
38 result(s) found for: Sigmoid.
Displaying page 1 of 2.
EudraCT Number: 2005-000182-19 | Sponsor Protocol Number: CC0401 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Phönix Laboratorium GmbH | |||||||||||||
Full Title: Wirksamkeit und Verträglichkeit von Cholincitrat bei postoperativer Darmatonie nach laparotomischer linksseitiger Hemikolektomie, Sigmaresektion oder Rektumresektion ohne endständiges oder protekti... | |||||||||||||
Medical condition: Postoperative intestinal atony | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-001561-28 | Sponsor Protocol Number: HES08 | Start Date*: 2008-07-21 |
Sponsor Name:Klinik für Anästhesiologie und Operative Intensivmedizin Klinikum Ludwigshafen | ||
Full Title: Influence of perioperative HES 130/04 adminstration on postoperative complications: A prospective randomized trial in patients undergoing colorectal surgery. | ||
Medical condition: Adult patients (>18 years) of both gender undergoing elective colorectal surgery (hemicolectomy left/right, sigmoid colectomy, rectal resection/amputation) without concomitant resection of liver me... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-003169-19 | Sponsor Protocol Number: CYC-201 | Start Date*: 2009-11-09 | |||||||||||
Sponsor Name:Sigmoid Pharma Ltd | |||||||||||||
Full Title: A Randomized, Double-blind, Placebo-controlled Study of a Controlled Release Minicapusle Formulation of Ciclosporin (CyCol™) in the Treatment of Ulcerative Colitis | |||||||||||||
Medical condition: Ulcerative colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IE (Completed) GB (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-001815-29 | Sponsor Protocol Number: MDL_2011_36557 | Start Date*: 2011-11-11 | |||||||||||
Sponsor Name:UMC Utrecht | |||||||||||||
Full Title: Chemopreventive effects of mesalazine in patients at high risk of recurrent (nonfamilial) colorectal adenomas | |||||||||||||
Medical condition: sporadic colorectal adenomas | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2008-007292-25 | Sponsor Protocol Number: GIU-5-ASA 1.2MMx-02-08 | Start Date*: 2009-03-24 | |||||||||||
Sponsor Name:GIULIANI | |||||||||||||
Full Title: AN OPEN, PILOT PHASE III, RANDOMIZED CLINICAL TRIAL TO ASSESS THE TISSUTAL PHARMAKINETICS OF MESALAZINE TABLETS IN PATIENTS WITH MILD TO MODERATE LEFT-SIDED ULCERATIVE COLITIS IN ACTIVE PHASE | |||||||||||||
Medical condition: Patients with established diagnosis of left-sided UC (rectum-sigmoid colon or colon up to the splenic flexure) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2022-000942-14 | Sponsor Protocol Number: 0243CT01 | Start Date*: 2022-10-20 |
Sponsor Name:Kissei Pharmaceutical Co., Ltd. | ||
Full Title: A Phase IIa, randomized, double-blind, placebo-controlled, multicentre study of a once daily multiple oral administration of KSP-0243 in patients with mild-to-moderate ulcerative colitis | ||
Medical condition: Ulcerative colitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: RO (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2007-004896-20 | Sponsor Protocol Number: SPD476-314 | Start Date*: 2008-05-20 | |||||||||||
Sponsor Name:Shire Pharmaceutical Development Limited | |||||||||||||
Full Title: A Phase III, Randomised, Double-Blind, Dose-Response, Stratified, Placebo-Controlled Study Evaluating the Safety and Efficacy of SPD476 versus Placebo over 104 weeks in the Prevention of Recurrence... | |||||||||||||
Medical condition: Treatment of Diverticulitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) FI (Completed) DE (Completed) IT (Completed) HU (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-004746-16 | Sponsor Protocol Number: AMCH06071 | Start Date*: 2006-10-30 |
Sponsor Name:Atrium Medisch Centrum Parkstad | ||
Full Title: Darmvoorbereiding bij linkszijdige colonchirurgie | ||
Medical condition: Bowel preparation for elective left-sided colonic surgery will be investigated. Medical conditions requiring this type of treatment vary, examples are inflammatory and malignant diseases. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2019-000617-37 | Sponsor Protocol Number: NL68690.091.18 | Start Date*: 2019-07-11 |
Sponsor Name:Rijnstate ziekenhuis | ||
Full Title: StudY of effect of Nimodipine and Acetaminophen on Postictal Symptoms after ECT | ||
Medical condition: Postictal phenomena after electroconvulsive therapy (ECT) induced seizures. | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2013-002506-31 | Sponsor Protocol Number: REPREB1 | Start Date*: 2013-12-16 |
Sponsor Name:Dr Antonio Gimeno | ||
Full Title: Clinical trial phase IV, randomized, to evaluate the efficacy of Polyethylene glycol plus ascorbic acid vs Polyethylene glycol alone in patients with a history of poorly prepared colonoscopy . | ||
Medical condition: outpatients with past poor bowel preparation, defined as a score less than 5, according to the Boston scale | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2022-003817-12 | Sponsor Protocol Number: 2021/0384/HP | Start Date*: 2023-05-15 | |||||||||||
Sponsor Name:CHU de Rouen | |||||||||||||
Full Title: Mechanisms of action on rectal motility of intrarectal botulinum toxin injections in patients with fecal incontinence | |||||||||||||
Medical condition: Patients with fecal incontinence who have failed conservative treatments and are candidates for intrarectal botulinum toxin injections. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-000319-18 | Sponsor Protocol Number: FW-UC-001 | Start Date*: 2018-02-07 | |||||||||||||||||||||
Sponsor Name:FIRST WAVE BIOPHARMA INCORPORATION | |||||||||||||||||||||||
Full Title: A phase I/IIa, open-label, three-stage, study to investigate the safety, the efficacy and the pharmacokinetics of Niclosamide enemas in subjects with active Ulcerative Proctitis or Ulcerative Proct... | |||||||||||||||||||||||
Medical condition: Active ulcerative proctitis or ulcerative procto-sigmoiditis | |||||||||||||||||||||||
|
|||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||
Trial protocol: IT (Completed) DE (Prematurely Ended) AT (Completed) | |||||||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-004599-36 | Sponsor Protocol Number: SB012/01/2013 | Start Date*: 2014-04-23 |
Sponsor Name:sterna biologicals GmbH & Co. KG | ||
Full Title: SB012 for the treatment of active ulcerative colitis (SECURE): a prospective, multi-centre, randomised, double-blind, placebo-controlled phase IIa clinical trial to evaluate the efficacy, pharmacok... | ||
Medical condition: Active ulcerative colitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2018-000013-20 | Sponsor Protocol Number: 2018-000013-20 | Start Date*: 2018-05-07 |
Sponsor Name:KU Leuven | ||
Full Title: Placebo-controlled crossover study of the ability of Naloxegol to reverse opioid effect on colonic motor patterns in healthy volunteers | ||
Medical condition: This study will be performed in healthy volunteers. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2020-000835-33 | Sponsor Protocol Number: 300513 | Start Date*: 2020-04-15 | |||||||||||
Sponsor Name:Zealand University Hospital | |||||||||||||
Full Title: Neoadjuvant electrochemotherapy for colorectal cancer – a randomized controlled trial | |||||||||||||
Medical condition: Colorectal cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-001062-10 | Sponsor Protocol Number: 000121 | Start Date*: 2014-11-03 | |||||||||||
Sponsor Name:Ferring Pharmaceuticals A/S | |||||||||||||
Full Title: A randomised, assessor-blinded, multi-centre trial comparing the efficacy, safety and tolerability of the PICOPREP tailored dosing schedule to the PICOPREP day-before dosing schedule for colon clea... | |||||||||||||
Medical condition: Bowel cleansing | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002856-18 | Sponsor Protocol Number: Mannitol_03-2018 | Start Date*: 2020-06-04 | |||||||||||
Sponsor Name:NTC s.r.l. | |||||||||||||
Full Title: Efficacy and Safety of mAnniTol in bowel preparation: assessment of adequacy and presence of Intestinal levelS of hydrogen and methane during elective colonoscopy aFter mAnnitol or standard split 2... | |||||||||||||
Medical condition: Subjects scheduled for elective colonoscopy to be prepared and performed according to ESGE (European Society of Gastrointestinal Endoscopy - ESGE) guidelines. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Completed) DE (Completed) IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2021-002549-13 | Sponsor Protocol Number: CSUC-01/21 | Start Date*: 2021-09-07 | |||||||||||
Sponsor Name:InDex Pharmaceuticals | |||||||||||||
Full Title: A Randomised Double-Blind Placebo-Controlled Phase III Clinical Study to Evaluate the Efficacy and Safety of Cobitolimod as an Induction and Maintenance Therapy in Participants with Moderate to ... | |||||||||||||
Medical condition: Moderate to Severe left-sided Active Ulcerative Colitis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Prematurely Ended) DE (Ongoing) HU (Prematurely Ended) FR (Prematurely Ended) SK (Prematurely Ended) LT (Prematurely Ended) IT (Prematurely Ended) AT (Prematurely Ended) PT (Prematurely Ended) NO (Prematurely Ended) BE (Completed) DK (Prematurely Ended) HR (Prematurely Ended) NL (Prematurely Ended) BG (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2015-000481-58 | Sponsor Protocol Number: MLN0002SC-3031 | Start Date*: 2016-01-22 | |||||||||||
Sponsor Name:Takeda Development Centre Europe, Ltd. | |||||||||||||
Full Title: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Vedolizumab Subcutaneous as Maintenance Therapy in Subjects With Moderately to Severely Active Cr... | |||||||||||||
Medical condition: Crohn’s Disease | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: SK (Completed) CZ (Completed) NL (Completed) BG (Completed) GB (Completed) DE (Completed) BE (Completed) SE (Completed) DK (Completed) LT (Completed) HU (Completed) ES (Completed) IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-000259-33 | Sponsor Protocol Number: 06-AnIt-06 | Start Date*: 2007-08-16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Department of Anesthesiology and Intensive Care, University Hospital Münster | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Perioperative protective effects of lidocaine - clinical study on the route and timing of administration | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: patients, scheduled for major elective colorectal surgery | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: DE (Prematurely Ended) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
